Sec. 7302. Asthma-related activities of the Centers for Disease Control and Prevention
839 words·~4 min read·
/bill/117/s/4486/is/section-7302·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 317I of the Public Health Service Act ( 42 U.S.C. 247b–10 ) is amended to read as follows: The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall collaborate with State and local health departments to conduct activities, including the provision of information and education to the public regarding asthma including— deterring the harmful consequences of uncontrolled asthma; and disseminating health education and information regarding prevention of asthma episodes and strategies for managing asthma.
The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall collaborate with State and local health departments to develop State plans incorporating public health responses to reduce the burden of asthma, particularly regarding disproportionately affected populations. The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall, in cooperation with State and local public health officials— conduct asthma surveillance activities to collect data on the prevalence and severity of asthma, the effectiveness of public health asthma interventions, and the quality of asthma management, including— collection of data among people with asthma to monitor the impact on health and quality of life; surveillance of health care facilities; and collection of data not containing individually identifiable information from electronic health records or other electronic communications; compile and annually publish data regarding the prevalence and incidence of childhood asthma, the child mortality rate, and the number of hospital admissions and emergency department visits by children associated with asthma nationally and in each State and at the county level by age, sex, race, and ethnicity, as well as lifetime and current prevalence; and compile and annually publish data regarding the prevalence and incidence of adult asthma, the adult mortality rate, and the number of hospital admissions and emergency department visits by adults associated with asthma nationally and in each State and at the county level by age, sex, race, ethnicity, industry, and occupation, as well as lifetime and current prevalence.
The Director of the Centers for Disease Control and Prevention, in conjunction with State and local health departments, shall coordinate data collection activities under paragraphs
(2)and
(3)of subsection
(c)so as to maximize comparability of results. The Centers for Disease Control and Prevention may collaborate with national, State, and local nonprofit organizations to provide information and education about asthma, and to strengthen such collaborations when possible. The Director of the Centers for Disease Control and Prevention, acting through the Division of Population Health of the Centers, may expand activities relating to asthma with non-Federal partners, especially State-level entities. Not later than 3 years after the date of the enactment of the Health Equity and Accountability Act of 2022 , and once 2 years thereafter, the Secretary shall, in consultation with patient groups, nonprofit organizations, medical societies, and other relevant governmental and nongovernmental entities, submit to Congress a report that— catalogs, with respect to asthma prevention, management, and surveillance— the activities of the Federal Government, including an assessment of the progress of the Federal Government and States, with respect to achieving the goals of the Healthy People 2030 initiative; and the activities of other entities that participate in the program under this section, including nonprofit organizations, patient advocacy groups, and medical societies; and makes recommendations for the future direction of asthma activities, in consultation with researchers from the National Institutes of Health and other member bodies of the Asthma Disparities Subcommittee, including— a description of how the Federal Government may improve its response to asthma, including identifying any barriers that may exist; a description of how the Federal Government may continue, expand, and improve its private-public partnerships with respect to asthma including identifying any barriers that may exist; identification of steps that may be taken to reduce the— morbidity, mortality, and overall prevalence of asthma; financial burden of asthma on society; burden of asthma on disproportionately affected areas, particularly those in medically underserved populations (as defined in section 330(b)(3)); and burden of asthma as a chronic disease that can be worsened by environmental exposures; the identification of programs and policies that have achieved the steps described under clause (iii), and steps that may be taken to expand such programs and policies to benefit larger populations; and recommendations for future research and interventions. During the 5-year period following the submission of the second report under paragraph (1), the Secretary shall submit updates and revisions of the report upon the request of the Congress. At the end of the 5-year period referred to in subparagraph (A), the Secretary shall— evaluate the analyses and recommendations made in previous reports; and determine whether an additional report is needed and if so submit such an updated report to the Congress, including appropriate recommendations. In addition to any other authorization of appropriations that is available to the Centers for Disease Control and Prevention for the purpose of carrying out this section, there is authorized to be appropriated to such Centers $65,000,000 for the period of fiscal years 2023 through 2027 for the purpose of carrying out this section. .
Connections1 off-index
1 reference not yet in our index
- 42 USC 247b–10
Citation graph
cites case law
Sec. 7302
Asthma-related activities of the Centers for Disease Control and Prevention
Cite42 USC 247b–10
Cites 1Cited by 0 across 0 sources